• EI
  • Scopus
  • 中国科技期刊卓越行动计划项目资助期刊
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国精品科技期刊
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国科技核心期刊CSTPCD
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
潘胜国,王群,刘制杰,等. 乳酸菌发酵对枇杷汁体外降血糖、降血脂活性的影响[J]. 宝威体育平台,2025,46(7):1−8. doi: 10.13386/j.issn1002-0306.2024050345.
引用本文: 潘胜国,王群,刘制杰,等. 乳酸菌发酵对枇杷汁体外降血糖、降血脂活性的影响[J]. 宝威体育平台,2025,46(7):1−8. doi: 10.13386/j.issn1002-0306.2024050345.
PAN Shengguo, WANG Qun, LIU Zhijie, et al. Effect of Lactic Acid Bacteria Fermentation on the Hypoglycemic and Hypolipidemic Activities of Loquat Juice in Vitro[J]. Science and Technology of Food Industry, 2025, 46(7): 1−8. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024050345.
Citation: PAN Shengguo, WANG Qun, LIU Zhijie, et al. Effect of Lactic Acid Bacteria Fermentation on the Hypoglycemic and Hypolipidemic Activities of Loquat Juice in Vitro[J]. Science and Technology of Food Industry, 2025, 46(7): 1−8. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024050345.

乳酸菌发酵对枇杷汁体外降血糖、降血脂活性的影响

Effect of Lactic Acid Bacteria Fermentation on the Hypoglycemic and Hypolipidemic Activities of Loquat Juice in Vitro

  • 摘要: 为评价乳酸菌发酵枇杷汁的功能特性,以枇杷汁为原料,短乳杆菌(Lactobacillus brevis)、副干酪乳杆菌(Lacticaseibacillus paracasei)、植物乳杆菌(Lactiplantibacillus plantarum)3株乳酸菌为发酵菌株,对枇杷汁发酵前后的体外降血糖和降血脂活性进行研究。结果表明,降血糖方面,L. brevis菌悬液对α-葡萄糖苷酶和α-淀粉酶活性抑制能力最强,抑制率分别为96.15%±1.54%和96.56%±2.16%;L. brevis发酵枇杷汁在透析30 min和60 min后葡萄糖透析延迟指数(glucose dialysis retardation index,GDRI)最高,分别为16.49%±0.40%与9.76%±0.32%,显著高于枇杷汁与L. paracaseiL. plantarum发酵枇杷汁(P<0.05);降血脂方面,L. brevis胞外分泌物对胰脂肪酶抑制率最高,达到62.36%±1.48%;L. brevis发酵枇杷汁对甘氨胆酸钠、牛磺胆酸钠的结合能力最强,分别为64.63%±1.49%与67.19%±1.19%;在脂肪吸附能力上,L. brevis发酵枇杷汁吸附脂肪能力为1.66±0.11 g/g。L. brevis发酵的枇杷汁在降血糖和降血脂活性上优于L. paracaseiL. plantarum发酵的枇杷汁,为枇杷功能性产品的开发提供参考。

     

    Abstract: In order to evaluate the functional characteristics of loquat juice fermented with lactic acid bacteria, the loquat juice was used as raw material and the Lactobacillus brevis, Lacticaseibacillus paracasei and Lactiplantibacillus plantarum were used as fermentation strains to study on hypoglycemic and hypolipidemic activities in vitro. The results showed that, for hypoglycemia, bacterial suspension of L. brevis had the strongest inhibitory ability on α-glucosidase and α-amylase activities compared to the other two strains, and inhibition ratio were 96.15%±1.54% and 96.56%±2.16% respectively. The glucose dialysis retardation index (GDRI) of loquat juice fermented by L. brevis was the highest after 30 min and 60 min of dialysis, with 16.49%±0.40% and 9.76%±0.32% respectively, which was significantly higher than L. paracasei and L. plantarum (P<0.05). For hypolipidemic, the L. brevis extracellular secretion had the highest inhibition rate of pancreatic lipase, with 62.36%±1.48%. The loquat juice fermented by L. brevis had the strongest binding capacity for sodium glycochenodeoxycholate and sodium taurocholate, with 64.63%±1.49% and 67.19%±1.19% respectively. In terms of fat adsorption capacity, the fat adsorption capacity of loquat juice fermented by L. brevis had the strongest adsorption capacity of 1.66±0.11 g/g. The loquat juice fermented by L. brevis were significantly better than L. paracasei and L. plantarum with hypoglycemic and hypolipidemic activities, which provides a reference for the development of loquat functional products.

     

/

返回文章
返回